Bank of America
CEROW

Bank of America’s CERo Therapeutics Warrants CEROW Stock Holding History

Bank of America’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-500
Closed -$4 – 8605
2024
Q4 		$4 Sell
500
-300
-38% -$3 ﹤0.01% 8125
2024
Q3 		$4 Buy
800
+100
+14% +$2 ﹤0.01% 8098
2024
Q2 		$14 Buy
700
+500
+250% +$29 ﹤0.01% 8055
2024
Q1 		$14 Hold
200
– – ﹤0.01% 7519
2023
Q4 		$5 Buy
+200
New +$6 ﹤0.01% 7858

Other funds holding CEROW

CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return

Bank of America's CEROW Position: Q1 2025 in Review

Bank of America sold out of CERo Therapeutics Warrants (CEROW) in Q1 2025, closing a stake of 500 shares — an estimated $4 sold.

Bank of America first reported a position in CEROW in Q4 2023 and held it in 5 quarters. The position peaked at $14 in Q2 2024. 26 funds tracked by Wall St. Rank hold CEROW as of Q1 2025.

  • Bank of America reported no remaining CERo Therapeutics Warrants position as of Q1 2025 after selling out during the quarter.
  • Bank of America sold 500 CERo Therapeutics Warrants shares in Q1 2025, an estimated $4.
  • Bank of America first reported a position in CERo Therapeutics Warrants in Q4 2023 and held it in 5 quarters.
  • Bank of America's CERo Therapeutics Warrants position peaked at $14 in Q2 2024.
  • 26 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q1 2025.

Based on Bank of America's 13F filing for Q1 2025, filed 15 May 2025.